Adaeze Nwosu-Iheme1 article listing Adaeze Nwosu-Iheme in Nature Communications, indexed by Paperzzz from Crossref and OSF.Zanidatamab in patients with early stage HER2-positive breast cancer: the NeoZanHER phase 2 single-arm open-label trial Nature Communications